Intent To Grant an Exclusive License of U.S. Government-Owned Patents, 29057 [2017-13408]
Download as PDF
mstockstill on DSK30JT082PROD with NOTICES
Federal Register / Vol. 82, No. 122 / Tuesday, June 27, 2017 / Notices
smalltooth sawfish to develop
conservation and protective measures,
ensuring species recovery. Other listed
species potentially encountered and
incidentally collected include green,
hawksbill, Kemp’s ridley, leatherback,
and loggerhead sea turtles. Researchers
may capture smalltooth sawfish in
Florida waters, and then measure,
weigh, tag, genetic tissue sample, draw
blood, and photograph the animals prior
to release. The researchers will also
receive salvaged animals and parts
taken at other locations within the target
species’ range. The permit is valid
through May 31, 2022.
Permit No. 21155: The requested
permit (82 FR 13801) authorizes the
importation of 118 DNA samples from
the Federal University of Rio Grande Do
Sul in Brazil to the University of
Michigan, Ecology and Evolutionary
Biology Department in Ann Arbor, MI,
for genetics research. The Atlantic
spotted dolphins (Stenella frontalis)
samples were collected between 1996
and 2016 via biopsy sampling of live
animals or from stranded animals, in
accordance with the laws of Brazil. The
permit also authorizes the export of any
remaining samples back to Brazil. The
permit is valid for five months.
Permit No. 21199: The requested
permit (82 FR 18739) authorizes the
BBC Natural History Unit to film killer
whales (Orcinus orca), Dall’s porpoise
(Phocoenoides dalli), and Pacific whitesided dolphins (Lagenorhynchus
obliquidens). Filming may occur near
Seward, Alaska over six days in May
2017 and in Juneau, AK over six days
at the end of July 2017. Filming would
occur from cameras on board a vessel or
by helicopter. Hydrophones would be
used to record vocalizations. Footage
would be used for an Alaska Live
television series to showcase the
gathering of wildlife in Alaska that
occurs around the salmon runs. The
permit is valid through August 31, 2017.
In compliance with the National
Environmental Policy Act of 1969 (42
U.S.C. 4321 et seq.), a final
determination has been made that the
activities proposed are categorically
excluded from the requirement to
prepare an environmental assessment or
environmental impact statement.
As required by the ESA, as applicable,
issuance of these permit was based on
a finding that such permits: (1) Were
applied for in good faith; (2) will not
operate to the disadvantage of such
endangered species; and (3) are
consistent with the purposes and
policies set forth in section 2 of the
ESA.
VerDate Sep<11>2014
18:33 Jun 26, 2017
Jkt 241001
Dated: June 22, 2017.
Catherine Marzin,
Acting Deputy Director, Office of Protected
Resources, National Marine Fisheries Service.
[FR Doc. 2017–13434 Filed 6–26–17; 8:45 am]
BILLING CODE 3510–22–P
DEPARTMENT OF DEFENSE
Department of the Air Force
U.S. Air Force Partially Exclusive
Patent License
Department of the Air Force,
Air Force Research Laboratory
Information Directorate, Rome, New
York, Department of Defense.
ACTION: Notice of intent to issue a
partially exclusive patent license.
AGENCY:
The Department of the Air
Force announces its intention to grant
Mentis Technologies, having a place of
business at 725 Daedalian Drive, Rome,
New York 13440, a partially exclusive
license in any right, title and interest the
United States Air Force has in: In U.S.
Patent No. 9,349,007 issued on May 24,
2016 and entitled ‘‘WEB MALWARE
BLOCKING THROUGH PARALLEL
RESOURCE RENDERING’’, having been
filed on May 29, 2014 as U.S. Patent
Application No. 14/290,175.
FOR FURTHER INFORMATION CONTACT: An
exclusive license for this patent will be
granted unless a written objection is
received within fifteen (15) days from
the date of publication of this Notice.
Written objections should be sent to: Air
Force Research Laboratory, Office of the
Staff Judge Advocate, AFRL/RIJ, 26
Electronic Parkway, Rome, New York
13441–4514. Telephone: (315) 330–
2087; Facsimile (315) 330–7583.
SUMMARY:
Authority: Pursuant to the provisions of
part 404 of Title 37, Code of Federal
Regulations, which implements Public Law
96–517, as amended.
Henry Williams,
Acting Air Force Federal Register Liaison
Officer.
[FR Doc. 2017–13402 Filed 6–26–17; 8:45 am]
BILLING CODE 5001–10–P
Department of the Army
Intent To Grant an Exclusive License
of U.S. Government-Owned Patents
Department of the Army, DoD.
Notice.
AGENCY:
ACTION:
In accordance with 35 U.S.C.
209(e) and 37 CFR 404.7(a)(1)(i),
SUMMARY:
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
announcement is made of the intent to
grant an exclusive, royalty-bearing,
revocable license to U.S. Patent
7,956,086, issued June 7, 2011, entitled,
‘‘Methods for the Formulation and
Manufacture of Artesunic Acid for
Injection’’ to Amivas, LLC, having its
principal place of business at 8403
Colesville Road, Suite 630, Silver
Spring, Maryland 20910.
ADDRESSES: Commander, U.S. Army
Medical Research and Materiel
Command, ATTN: Command Judge
Advocate, MCMR–JA, 504 Scott Street,
Fort Detrick, MD 21702–5012.
FOR FURTHER INFORMATION CONTACT: For
licensing issues, Mr. Barry Datlof, Office
of Research & Technology Applications,
(301) 619–0033. For patent issues, Ms.
Elizabeth Arwine, Patent Attorney, (301)
619–7808, both at telefax (301) 619–
5034.
Anyone
wishing to object to grant of this license
can file written objections along with
supporting evidence, if any, within 15
days from the date of this publication.
Written objections are to be filed with
the Command Judge Advocate (see
ADDRESSES).
SUPPLEMENTARY INFORMATION:
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2017–13408 Filed 6–26–17; 8:45 am]
BILLING CODE 5001–03–P
DEFENSE NUCLEAR FACILITIES
SAFETY BOARD
Sunshine Act Notice
Defense Nuclear Facilities
Safety Board.
ACTION: Notice of closed meeting.
AGENCY:
Pursuant to the provisions of
the Government in the Sunshine Act (5
U.S.C. 552b), and the Defense Nuclear
Facilities Safety Board’s (Board)
regulations implementing the
Government in the Sunshine Act, notice
is hereby given of the Board’s closed
meeting described below.
DATES: 10:00 a.m.–11:00 a.m., July 18,
2017.
SUMMARY:
Defense Nuclear Facilities
Safety Board, 625 Indiana Avenue NW.,
Suite 700, Washington, DC 20004.
FOR FURTHER INFORMATION CONTACT:
Glenn Sklar, General Manager, Defense
Nuclear Facilities Safety Board, 625
Indiana Avenue NW., Suite 700,
Washington, DC 20004–2901, (800) 788–
4016. This is a toll-free number.
SUPPLEMENTARY INFORMATION: The
meeting will be closed to the public. No
ADDRESSES:
DEPARTMENT OF DEFENSE
29057
E:\FR\FM\27JNN1.SGM
27JNN1
Agencies
[Federal Register Volume 82, Number 122 (Tuesday, June 27, 2017)]
[Notices]
[Page 29057]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-13408]
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Department of the Army
Intent To Grant an Exclusive License of U.S. Government-Owned
Patents
AGENCY: Department of the Army, DoD.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i),
announcement is made of the intent to grant an exclusive, royalty-
bearing, revocable license to U.S. Patent 7,956,086, issued June 7,
2011, entitled, ``Methods for the Formulation and Manufacture of
Artesunic Acid for Injection'' to Amivas, LLC, having its principal
place of business at 8403 Colesville Road, Suite 630, Silver Spring,
Maryland 20910.
ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command,
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick,
MD 21702-5012.
FOR FURTHER INFORMATION CONTACT: For licensing issues, Mr. Barry
Datlof, Office of Research & Technology Applications, (301) 619-0033.
For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-
7808, both at telefax (301) 619-5034.
SUPPLEMENTARY INFORMATION: Anyone wishing to object to grant of this
license can file written objections along with supporting evidence, if
any, within 15 days from the date of this publication. Written
objections are to be filed with the Command Judge Advocate (see
ADDRESSES).
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2017-13408 Filed 6-26-17; 8:45 am]
BILLING CODE 5001-03-P